Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis Journal Article


Authors: Liu, B.; Liu, Z.; Chen, S.; Ki, M.; Erickson, C.; Reis-Filho, J. S.; Durham, B. H.; Chang, Q.; de Stanchina, E.; Sun, Y.; Rabadan, R.; Abdel-Wahab, O.; Chandarlapaty, S.
Article Title: Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis
Abstract: Mutations in the core RNA splicing factor SF3B1 are prevalent in leukemias and uveal melanoma, but hotspot SF3B1 mutations are also seen in epithelial malignancies such as breast cancer. Although hotspot mutations in SF3B1 alter hematopoietic differentiation, whether SF3B1 mutations contribute to epithelial cancer development and progression is unknown. Here, we identify that SF3B1 mutations in mammary epithelial and breast cancer cells induce a recurrent pattern of aberrant splicing leading to activation of AKT and NF-κB, enhanced cell migration, and accelerated tumorigenesis. Transcriptomic analysis of human cancer specimens, MMTV-cre Sf3b1K700E/WT mice, and isogenic mutant cell lines identified hundreds of aberrant 3' splice sites (3'ss) induced by mutant SF3B1. Consistently between mouse and human tumors, mutant SF3B1 promoted aberrant splicing (dependent on aberrant branchpoints as well as pyrimidines downstream of the cryptic 3'ss) and consequent suppression of PPP2R5A and MAP3K7, critical negative regulators of AKT and NF-κB. Coordinate activation of NF-κB and AKT signaling was observed in the knockin models, leading to accelerated cell migration and tumor development in combination with mutant PIK3CA but also hypersensitizing cells to AKT kinase inhibitors. These data identify hotspot mutations in SF3B1 as an important contributor to breast tumorigenesis and reveal unique vulnerabilities in cancers harboring them. © 2021, American Society for Clinical Investigation.
Journal Title: Journal of Clinical Investigation
Volume: 131
Issue: 1
ISSN: 0021-9738
Publisher: American Society for Clinical Investigation  
Date Published: 2021-01-04
Start Page: e138315
Language: English
DOI: 10.1172/jci138315
PUBMED: 33031100
PROVIDER: scopus
PMCID: PMC7773370
DOI/URL:
Notes: Article -- Export Date: 1 February 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Qing Chang
    36 Chang
  2. Benjamin Heath Durham
    115 Durham
  3. Bo Liu
    24 Liu
  4. Michelle Carmen Ki
    16 Ki
  5. Sisi Chen
    14 Chen